Evan Leitner

Associate

+1 617 937 2449
eleitner@cooley.com

Evan Leitner has represented high growth companies and investment banks on capital markets and corporate transactions, including initial and follow-on public equity offerings and high-yield, investment-grade and convertible debt offerings. Evan also counsels publicly held companies with respect to corporate governance, SEC reporting and securities law compliance.

Download full bio

Experience

  • Datadog – $745 Million IPO 

  • Morphic Therapeutics - $104 Million IPO 

  • Akero Therapeutics - $106 Million IPO 

  • Bicycle Therapeutics - $61 Million IPO 

Education

  • New York University School of Law
    JD, 2015

  • Yale University
    BA, 2009


Admissions & Credentials

New York

New Jersey

Massachusetts

Media & Insight

Contact

+1 617 937 2449 office
eleitner@cooley.com

500 Boylston Street
14th Floor
Boston, MA 02116-3736